SCHEMBL13575083

SCHEMBL13575083

Nc1cccc(-c2ccc3nnc(Cc4cccc(-c5ncc(-c6cnn(CCN7CCCC7)c6)cn5)c4)n3n2)c1

nearest known ligand 0.43

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MET P08581 19/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1133703 0.91 MET (0.53) MET
SCHEMBL12730511 0.89 MET (0.51) MET
SCHEMBL12730478 0.86 MET (0.40) MET
SCHEMBL12224232 0.84 MET (0.39) MET
SCHEMBL13575024 0.83 MET (0.43) MET
SCHEMBL2456670 0.82 MET (0.36) MET
SCHEMBL12245549 0.82 BRAF (0.37) MET
SCHEMBL13970433 0.80 MET (0.55) MET
SCHEMBL12547601 0.76 PRMT6 (0.42) MET
SCHEMBL1133813 0.76 MET (0.54) MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009152920-A1 3-(3-PYRIMIDIN-2-YL-BENZYL)-[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES AS MET KINASE INHIBITORS MERCK PATENT GMBH (DE) 2009-12-23 WO disclosed